Bionano Genomics (BNGO) Shares Outstanding (Weighted Average) (2017 - 2026)

Bionano Genomics has disclosed Shares Outstanding (Weighted Average) across 10 years of filings, most recently posting $12.1 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $12.1 million, up 480.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.1 million (up 480.6% YoY), and the FY2025 annual result was $12.1 million, up 850.47% from the prior year.
• Shares Outstanding (Weighted Average) came in at $12.1 million for Q1 2026 at Bionano Genomics, roughly flat from $12.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $65.5 million in Q3 2024 to a low of $8000.0 in Q4 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $12.1 million (2025), against an average of $16.7 million.
• Across the five-year window, Shares Outstanding (Weighted Average) slumped 98.47% in 2023 and jumped 6879.36% in 2024, its largest moves.
• Bionano Genomics' Shares Outstanding (Weighted Average) stood at $8000.0 in 2022, then surged by 4425.0% to $362000.0 in 2023, then jumped by 251.1% to $1.3 million in 2024, then soared by 850.47% to $12.1 million in 2025, then changed by 0.0% to $12.1 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $12.1 million (Q1 2026), $12.1 million (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.